NCT01978327View on ClinicalTrials.gov

GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers

PHASE1TerminatedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

November 22, 2013

Primary Completion Date

March 3, 2014

Study Completion Date

March 3, 2014

Conditions

Alzheimer's Disease

Interventions

DRUG

GSK2647544

repeat dose

DRUG

drug-drug interaction

drug-drug interaction

Trial Locations (1)

HA1 3UJ

GSK Investigational Site, Harrow

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY